Literature DB >> 8724812

Streptogramins. A unique class of antibiotics.

J C Pechère1.   

Abstract

Streptogramin antibiotics represent a unique class of antibacterials in that each member of the class consists of at least 2 structurally unrelated molecules: group A streptogramins (macrolactones) and group B streptogramins (cyclic hexadepsipeptides). Both group A and group B streptogramins inhibit protein synthesis at the ribosomal level, and they act synergistically against many isolates, their combination generating bactericidal activities and reducing the possibility of emergence of resistant strains. The mechanisms of acquired resistance to group B streptogramins are similar to those induced by erythromycin, but group A streptogramins remain unaffected by target modifications and active efflux. The pharmacokinetic parameters of group A and group B streptogramins in blood are quite similar. In addition, both the A and B groups penetrate and accumulate in macrophages and in the bacterial vegetations of experimental endocarditis. There are important structural and biological differences between the streptogramins and the macrolides. The main differentiating features are the rapid anti-bacterial killing of streptogramins and the rarity of cross-resistance between the 2 groups of antibiotics.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8724812     DOI: 10.2165/00003495-199600511-00005

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  18 in total

Review 1.  Antibiotics of the virginiamycin family, inhibitors which contain synergistic components.

Authors:  C Cocito
Journal:  Microbiol Rev       Date:  1979-06

2.  A phase I, double-blind, placebo-controlled study of the tolerance and pharmacokinetic behaviour of RP 59500.

Authors:  S D Etienne; G Montay; A Le Liboux; A Frydman; J J Garaud
Journal:  J Antimicrob Chemother       Date:  1992-07       Impact factor: 5.790

3.  Post-antibiotic effects of RP 59500 with Staphylococcus aureus.

Authors:  A Nougayrede; N Berthaud; D H Bouanchaud
Journal:  J Antimicrob Chemother       Date:  1992-07       Impact factor: 5.790

4.  In-vitro activity of RP 59500, a semisynthetic streptogramin, against staphylococci and streptococci.

Authors:  J C Pechère
Journal:  J Antimicrob Chemother       Date:  1992-07       Impact factor: 5.790

5.  Single oral dose pharmacokinetics of the two main components of pristinamycin in humans.

Authors:  C Koechlin; J F Kempf; F Jehl; H Monteil
Journal:  J Antimicrob Chemother       Date:  1990-04       Impact factor: 5.790

6.  Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology.

Authors:  G A Pankuch; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

7.  [Study of the bactericidal activity of pristinamycin ].

Authors:  D Videau
Journal:  Pathol Biol (Paris)       Date:  1982-06

8.  Cellular uptake and intracellular bactericidal activity of RP 59500 in murine macrophages.

Authors:  J F Desnottes; N Diallo
Journal:  J Antimicrob Chemother       Date:  1992-07       Impact factor: 5.790

9.  Antimicrobial activity against Staphylococcus aureus of semisynthetic injectable streptogramins: RP 59500 and related compounds.

Authors:  J C Barrière; D H Bouanchaud; J M Paris; O Rolin; N V Harris; C Smith
Journal:  J Antimicrob Chemother       Date:  1992-07       Impact factor: 5.790

10.  Comparative in-vitro activity of RP 59500.

Authors:  L Verbist; J Verhaegen
Journal:  J Antimicrob Chemother       Date:  1992-07       Impact factor: 5.790

View more
  5 in total

1.  Quinupristin/dalfopristin: the first available macrolide-lincosamide-streptogramin antibiotic.

Authors:  C Gurk-Turner
Journal:  Proc (Bayl Univ Med Cent)       Date:  2000-01

2.  In vitro activities of quinupristin-dalfopristin and the streptogramin RPR 106972 against Mycoplasma pneumoniae.

Authors:  K Izumikawa; Y Hirakata; T Yamaguchi; R Yoshida; H Tanaka; H Takemura; S Maesaki; K Tomono; M Kaku; K I Izumikawa; S Kamihira; S Kohno
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

3.  Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark.

Authors:  F M Aarestrup; A M Seyfarth; H D Emborg; K Pedersen; R S Hendriksen; F Bager
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

4.  Identification of a streptogramin A acetyltransferase gene in the chromosome of Yersinia enterocolitica.

Authors:  A Seoane; J M García Lobo
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

Review 5.  Streptogramins and their potential role in geriatric medicine.

Authors:  B M Lomaestro; L L Briceland
Journal:  Drugs Aging       Date:  1998-12       Impact factor: 3.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.